The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.3M Compounds and 9.3K Targets. Of those, 1,372K data for 638K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.EBI
Johns Hopkins Medical Institutions
Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine.EBI
TBA
Synthesis and biological activity of analogues of beta-chlornaltrexamine and beta-funaltrexamine at opioid receptors.EBI
TBA
Replacement of the peptide-backbone amides connecting Tyr-Gly and Gly-Gly in leucine-enkephalin with ketomethylene groups: synthesis and biological activity.EBI
TBA
Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.EBI
TBA
N-Methylnalorphine: definition of N-allyl conformation for antagonism at the opiate receptor.EBI
TBA
Synthesis and pharmacology of metabolically stable tert-butyl ethers of morphine and levorphanol.EBI
TBA
Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability.EBI
University of Northern Colorado
Opioid agonist and antagonist activities of morphindoles related to naltrindole.EBI
University of Minnesota
Structure-affinity relationship studies on 5-HT1A receptor ligands. 1. Heterobicyclic phenylpiperazines with N4-alkyl substituents.EBI
Solvay Duphar Research Laboratories
Design and synthesis of highly potent and selective cyclic dynorphin A analogues.EBI
University of Arizona